Basic Mechanisms of Brain Injury and Cognitive Decline in Hypertension

被引:14
|
作者
Baggeroer, Caroline E. [1 ]
Cambronero, Francis E. [1 ]
Savan, N. Anna [4 ]
Jefferson, Angela L. [1 ,2 ,3 ]
Santisteban, Monica M. [1 ,2 ,3 ,5 ]
机构
[1] Vanderbilt Univ, Vanderbilt Memory & Alzheimers Ctr, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[4] Yale Univ, Med Scientist Training Program, New Haven, CT USA
[5] Vanderbilt Univ, Med Ctr, 2213 Garland Ave,Suite 1235 Light Hall, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
cerebral small vessel disease; cognitive decline; dementia; hypertension; neurovascular unit; CEREBRAL-BLOOD-FLOW; SCIENTIFIC STATEMENT; ENDOTHELIAL DYSFUNCTION; MICROVASCULAR PERICYTES; ARTERIAL STIFFNESS; IMPAIRMENT; RATS; MICE; MACROPHAGES; PRESSURE;
D O I
10.1161/HYPERTENSIONAHA.123.19939
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Dementia affects almost 50 million adults worldwide, and remains a major cause of death and disability. Hypertension is a leading risk factor for dementia, including Alzheimer disease and Alzheimer disease-related dementias. Although this association is well-established, the mechanisms underlying hypertension-induced cognitive decline remain poorly understood. By exploring the mechanisms mediating the detrimental effects of hypertension on the brain, studies have aimed to provide therapeutic insights and strategies on how to protect the brain from the effects of blood pressure elevation. In this review, we focus on the basic mechanisms contributing to the cerebrovascular adaptions to elevated blood pressure and hypertension-induced microvascular injury. We also assess the cellular mechanisms of neurovascular unit dysfunction, focusing on the premise that cognitive impairment ensues when the dynamic metabolic demands of neurons are not met due to neurovascular uncoupling, and summarize cognitive deficits across various rodent models of hypertension as a resource for investigators. Despite significant advances in antihypertensive therapy, hypertension remains a critical risk factor for cognitive decline, and several questions remain about the development and progression of hypertension-induced cognitive impairment.
引用
收藏
页码:34 / 44
页数:11
相关论文
共 50 条
  • [1] Hypertension, Brain Damage and Cognitive Decline
    Gasecki, Dariusz
    Kwarciany, Mariusz
    Nyka, Walenty
    Narkiewicz, Krzysztof
    CURRENT HYPERTENSION REPORTS, 2013, 15 (06) : 547 - 558
  • [2] Hypertension, Brain Damage and Cognitive Decline
    Dariusz Gąsecki
    Mariusz Kwarciany
    Walenty Nyka
    Krzysztof Narkiewicz
    Current Hypertension Reports, 2013, 15 : 547 - 558
  • [3] Hypertension, cognitive decline and dementia
    Duron, E.
    Hanon, O.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (03) : 181 - 189
  • [4] Hypertension, Neurodegeneration, and Cognitive Decline
    Pacholko, Anthony
    Iadecola, Costantino
    HYPERTENSION, 2024, 81 (05) : 991 - 1007
  • [5] Contributing Factors to Diabetic Brain Injury and Cognitive Decline
    Verma, Nirmal
    Despa, Florin
    DIABETES & METABOLISM JOURNAL, 2019, 43 (05) : 560 - 567
  • [6] Cognitive Decline as a Consequence of Essential Hypertension
    Grassi, Davide
    Ferri, Livia
    Cheli, Paola
    Di Giosia, Paolo
    Ferri, Claudio
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (28) : 3032 - 3038
  • [7] Effect of plasma lipids, hypertension and APOE genotype on cognitive decline
    Yasuno, Fumihiko
    Tanimukai, Satoshi
    Sasaki, Megumi
    Ikejima, Chiaki
    Yamashita, Fumio
    Kodama, Chiine
    Hidaka, Shin
    Mizukami, Katsuyoshi
    Asada, Takashi
    NEUROBIOLOGY OF AGING, 2012, 33 (11) : 2633 - 2640
  • [8] Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline
    Morrison, Cassandra
    Dadar, Mahsa
    Shafiee, Neda
    Villeneuve, Sylvia
    Collins, D. Louis
    NEUROIMAGE-CLINICAL, 2022, 33
  • [9] Subclinical HMOD in Hypertension: Brain Imaging and Cognitive Function
    Scuteri, Angelo
    Incalzi, Raffaele Antonelli
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (06) : 577 - 583
  • [10] Evidence and mechanisms for statin-induced cognitive decline
    Tan, Brendan
    Rosenfeldt, Franklin
    Ou, Ruchong
    Stough, Con
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (05) : 397 - 406